JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2005;58:1002-1004; doi:10.1136/jcp.2005.026252
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mottok, A
Right arrow Articles by Bräuninger, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mottok, A
Right arrow Articles by Bräuninger, A
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Hodgkin's Disease

SHORT REPORT

Activation induced cytidine deaminase expression in lymphocyte predominant Hodgkin lymphoma

A Mottok, M-L Hansmann, A Bräuninger

Department of Pathology, University of Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany

Correspondence to:
Dr A Bräuninger
Department of Pathology, University of Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany; braeuninger{at}em.uni-frankfurt.de
ABSTRACT
Background: The lymphocytic and histiocytic (L&H) cells of lymphocyte predominant Hodgkin lymphoma (HL) originate from germinal centre B cells and carry mutated V gene rearrangements, usually with intraclonal diversity. It is unclear whether intraclonal V gene diversification by somatic hypermutation, which is strictly dependent on the enzyme activation induced cytidine deaminase (AID), is restricted to the early phase of lymphoma clone expansion and later silenced, or whether it remains active throughout malignant proliferation.

Aims: To analyse whether AID is expressed in L&H cells as an indicator of active somatic hypermutation in the tumour cells.

Methods: L&H cells from lymphocyte predominant HL cases and centroblasts from lymphadenites were micromanipulated and analysed for AID expression by quantitative real time polymerase chain reaction.

Results: The AID transcription level was higher than background in three of the six lymphocyte predominant HL cases, although it was lower than that seen in centroblasts.

Conclusions: Somatic hypermutation may remain active in L&H cells in a considerable proportion of cases, increasing the risk of acquiring further transforming mutations.


Abbreviations: AID, activation induced cytidine deaminase; Ct, threshold cycle; GC, germinal centre; HL, Hodgkin lymphoma; L&H, lymphocytic and histiocytic; PCR, polymerase chain reaction; RT, reverse transcription

Keywords: lymphocyte predominant Hodgkin lymphoma; activation induced cytidine deaminase; somatic hypermutation; intraclonal diversity; quantitative real time polymerase chain reaction




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. W. Popov, G. Moldenhauer, B. Wotschke, S. Bruderlein, T. F. Barth, K. Dorsch, O. Ritz, P. Moller, and F. Leithauser
Target Sequence Accessibility Limits Activation-Induced Cytidine Deaminase Activity in Primary Mediastinal B-Cell Lymphoma
Cancer Res., July 15, 2007; 67(14): 6555 - 6564.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.